<unk> s resulted in 29,000 deaths worldwide in 2013 up from 14,000 deaths in 1990. Each year, more than 2.5 million people in the United States develop<unk> s. In acute care settings in the United States, the incidence of bedsores is 0.4% to 38%; within long-term care it is 2.2% to 23.9%, and in home care, it is 0% to 17%. Similarly, there is wide variation in prevalence: 10% to 18% in acute care, 2.3% to 28% in long-term care, and 0% to 29% in home care. There is a much higher rate of bedsores in intensive care units because of immunocompromised individuals, with 8% to 40% of those in the ICU developing bedsores. However,<unk>  prevalence is highly dependent on the methodology used to collect the data. Using the European<unk>  Advisory Panel (EPUAP) methodology there are similar figures for<unk> s in acutely sick people in the hospital. There are differences across countries, but using this methodology,<unk>  prevalence in Europe was consistently high, from 8.3% (Italy) to 22.9% (Sweden). A recent study in Jordan also showed a figure in this range. Some research shows differences in<unk>  detection among white and black residents in nursing homes.
Pressure ulcer
Venous ulcer
Arterial insufficiency ulcer
Hair loss
Linguatulosis
Gangrene
Diabetic foot ulcer
Veinoplus